These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 35546997)

  • 1. Improving Combination Osteoporosis Therapy in a Preclinical Model of Heightened Osteoanabolism.
    Shao Y; Hernandez-Buquer S; Childress P; Stayrook KR; Alvarez MB; Davis H; Plotkin LI; He Y; Condon KW; Burr DB; Warden SJ; Robling AG; Yang FC; Wek RC; Allen MR; Bidwell JP
    Endocrinology; 2017 Sep; 158(9):2722-2740. PubMed ID: 28637206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PTH(1-34) and zoledronic acid have differing longitudinal effects on juvenile mouse femur strength and morphology.
    Bartlow CM; Oest ME; Mann KA; Zimmerman ND; Butt BB; Damron TA
    J Orthop Res; 2017 Aug; 35(8):1707-1715. PubMed ID: 27653318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The potential role of SNHG16/ miRNA-146a/ TRAF6 signaling pathway in the protective effect of zoledronate against colorectal cancer and associated osteoporosis in mouse model.
    Helmy Mohamed A; Noureldin Hassan A; Hussein Abdel Hay N; Fouad Ahmed M; El Sawy MM; Sonbol MM; Hussein Mohamed R
    Int Immunopharmacol; 2024 May; 133():112125. PubMed ID: 38657499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intermittent parathyroid hormone enhances the healing of medication-related osteonecrosis of the jaw lesions in rice rats.
    Castillo EJ; Jiron JM; Croft CS; Freehill DG; Castillo CM; Kura J; Yarrow JF; Bhattacharyya I; Kimmel DB; Aguirre JI
    Front Med (Lausanne); 2023; 10():1179350. PubMed ID: 37404809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Skeletal accumulation of fluorescently tagged zoledronate is higher in animals with early stage chronic kidney disease.
    Swallow EA; Aref MW; Chen N; Byiringiro I; Hammond MA; McCarthy BP; Territo PR; Kamocka MM; Winfree S; Dunn KW; Moe SM; Allen MR
    Osteoporos Int; 2018 Sep; 29(9):2139-2146. PubMed ID: 29947866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cortical porosity is elevated after a single dose of zoledronate in two rodent models of chronic kidney disease.
    Swallow EA; Metzger CE; Chen NX; Wallace JM; Tippen SP; Kohler R; Moe SM; Allen MR
    Bone Rep; 2022 Jun; 16():101174. PubMed ID: 35252482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pre-implantation teriparatide administration improves initial implant stability and accelerates the osseointegration process in osteoporotic rats.
    Cui B; Bai T; Wu Q; Hu Y; Liu Y
    Int J Implant Dent; 2024 Apr; 10(1):18. PubMed ID: 38625587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A personalized biomimetic dual-drug delivery system via controlled release of PTH
    Xu T; Gao S; Yang N; Zhao Q; Zhang Y; Li T; Liu Z; Han B
    Front Bioeng Biotechnol; 2024; 12():1355019. PubMed ID: 38357710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The new bisphosphonate, Zometa (zoledronic acid), decreases skeletal complications in both osteolytic and osteoblastic lesions: a comparison to pamidronate.
    Lipton A; Small E; Saad F; Gleason D; Gordon D; Smith M; Rosen L; Kowalski MO; Reitsma D; Seaman J
    Cancer Invest; 2002; 20 Suppl 2():45-54. PubMed ID: 12442349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of bisphosphonates on osteoporosis: Focus on zoledronate.
    Oryan A; Sahvieh S
    Life Sci; 2021 Jan; 264():118681. PubMed ID: 33129881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Additive Effect of Parathyroid Hormone and Zoledronate Acid on Prevention Particle Wears-Induced Implant Loosening by Promoting Periprosthetic Bone Architecture and Strength in an Ovariectomized Rat Model.
    Zhou C; Wang Y; Meng J; Yao M; Xu H; Wang C; Bi F; Zhu H; Yang G; Shi M; Yan S; Wu H
    Front Endocrinol (Lausanne); 2022; 13():871380. PubMed ID: 35546997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of sequential treatment with intermittent parathyroid hormone and zoledronic acid on particle-induced implant loosening: Evidence from a rat model.
    Hu B; Wu H; Shi Z; Ying Z; Zhao X; Lin T; Hong J; Wang Y; Yang Y; Cai X; Yan S
    J Orthop Res; 2019 Jul; 37(7):1489-1497. PubMed ID: 30644138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intermittent Administration of Parathyroid Hormone [1-34] Prevents Particle-Induced Periprosthetic Osteolysis in a Rat Model.
    Bi F; Shi Z; Zhou C; Liu A; Shen Y; Yan S
    PLoS One; 2015; 10(10):e0139793. PubMed ID: 26441073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of combined treatment with zoledronic acid and propranolol on mechanical strength in an rat model of disuse osteoporosis.
    Khajuria DK; Razdan R; Mahapatra DR
    Rev Bras Reumatol; 2015; 55(6):501-11. PubMed ID: 25480532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Additive effect of zoledronic acid and alfacalcidol in the treatment of disuse osteoporosis in rats].
    Khajuria DK; Disha C; Razdan R; Mahapatra DR
    Rev Bras Reumatol; 2015; 55(3):240-50. PubMed ID: 25440697
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.